CERVical cancer: AdjuvaNt ThErapy and radical Surgery
CERVATES clinical trial
An international randomised trial of radical surgery followed by adjuvant therapy versus no further
treatment in patients with early-stage, intermediate-risk cervical cancer
Trial News
I. CERVANTES study (protocol version v2.0) is now under evaluation in Clinical Trial Information System (CTIS) for authorisation in Austria, Belgium, Italy, Poland and Spain.
Austria - 5 sites
Belgium - 5 sites - outhorised
Italy - 1 site
Poland - 5 sites
Spain - 6 sites
II. CERVANTES Portuguese translation under preparation for Brazilian International Review Board (IRB) - registration of 3 sites
III. 49 patients enrolled from 10 recruiting centres in 7 countries - 4 more sites are waiting for their first patient
Let' get together; ESGO 2026 CERVANTES meeting. Come and find out more about the possibility to open CERVANTES at your site and what news we have.
Friday 27.2.2026 18:00-18:30 ESGO meeting room 1
Subscribe for CERVANTES Trial
newsletter*